Boston Scientific Announces Results For First Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Boston Scientific (BSX) Misses Q1 EPS by 1c, Revenues Miss; Updates 2Q & FY19 EPS Guidance
April 24, 2019 6:33 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.35, $0.01 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.54 billion.
"Our global team and differentiated portfolio enabled us to deliver good sales and earnings growth this... More
